Post-treatment triglyceride-glucose index as survival protective factors in patients with esophageal squamous cell carcinoma

Table 2 Pearson correlation coefficients between post-treatment triglyceride-glucose-related indices and clinical characteristics

Group	TyG index		Clinical stage	RT dose	Chemotherapy	BMI	Survival time	Survival status
Total patients	PostTyG	R	-0.133	-0.024	0.079	0.049	-0.125	0.119
		P value	0.012	0.645	0.136	0.351	0.017	0.023
		FDR P value	0.036	0.572	0.294	0.341	0.341	0.045
	PostTyG-BW	R	-0.218	0.052	0.133	0.787	-0.151	0.2
		P value	< 0.001	0.329	0.012	< 0.001	0.004	< 0.001
		FDR P value	0.739	0.572	0.739	0.163	0.501	0.402
	PostTyG-BMI	R	-0.221	0.059	0.164	0.971	-0.146	0.21
		P value	< 0.001	0.264	0.002	< 0.001	0.005	< 0.001
		FDR P value	0.001	0.46	0.033	< 0.001	0.014	0.033
Male	PostTyG	R	-0.19	-0.016	0.096	0.075	-0.115	0.142
		P value	0.001	0.79	0.104	0.204	0.051	0.016
		FDR P value	0.008	0.615	0.196	0.341	0.288	0.112
	PostTyG-BW	R	-0.245	0.072	0.174	0.821	-0.163	0.257
		P value	< 0.001	0.223	0.003	< 0.001	0.006	< 0.001
		FDR P value	0.957	0.458	0.779	0.033	0.572	0.485
	PostTyG-BMI	R	-0.222	0.121	0.182	0.969	-0.152	0.269
		P value	< 0.001	0.04	0.002	< 0.001	0.01	< 0.001
		FDR P value	0.002	0.288	0.033	< 0.001	0.002	0.042
Female	PostTyG	R	0.089	-0.074	0.023	-0.047	-0.156	0.029
		P value	0.453	0.535	0.849	0.691	0.187	0.807
		FDR P value	0.679	0.787	0.957	0.823	0.988	0.415
	PostTyG-BW	R	-0.158	-0.212	0.117	0.726	-0.124	-0.018
		P value	0.183	0.071	0.323	< 0.001	0.296	0.88
		FDR P value	0.453	0.779	0.79	0.558	0.739	0.572
	PostTyG-BMI	R	-0.195	-0.258	0.117	0.964	-0.106	-0.055
		P value	0.098	0.028	0.323	< 0.001	0.373	0.641
		FDR P value	0.458	0.447	0.558	< 0.001	0.82	0.541

RT: Radiotherapy; BMI: Body mass index; TC: Total cholesterol; TG: Triglycerides; TyG: Triglyceride-glucose; TyG-BW: Triglyceride-glucose-body weight; TyG-BMI: Triglyceride-glucose-body mass index; FDR: False discovery rate.